Sec Form 4 Filing - GOLDBERG MURRAY A @ REGENERON PHARMACEUTICALS INC - 2012-11-13

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
GOLDBERG MURRAY A
2. Issuer Name and Ticker or Trading Symbol
REGENERON PHARMACEUTICALS INC [ REGN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
SVP Finance and Admin CFO Trea
(Last) (First) (Middle)
777 OLD SAW MILL RIVER ROAD
3. Date of Earliest Transaction (MM/DD/YY)
11/13/2012
(Street)
TARRYTOWN, NY10591
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/13/2012 M( 1 ) 4,745 A $ 65.76 95,259 D
Common Stock 11/13/2012 F( 1 ) 2,128 D $ 146.6 93,131 D
Common Stock 11/13/2012 F( 1 ) 1,205 D $ 146.6 91,926 D
Common Stock 11/13/2012 M( 1 ) 3,431 A $ 8.5 95,357 D
Common Stock 11/13/2012 F( 1 ) 198 D $ 146.6 95,159 D
Common Stock 11/13/2012 F( 1 ) 1,489 D $ 146.6 93,670 D
Common Stock 11/13/2012 S( 1 ) 200 D $ 144.36 93,470 D
Common Stock 11/13/2012 S( 1 ) 300 D $ 145.65 ( 2 ) 93,170 D
Common Stock 11/13/2012 S( 1 ) 1,400 D $ 146.58 ( 3 ) 91,770 D
Common Stock 11/13/2012 S( 1 ) 3,845 D $ 147.62 ( 4 ) 87,925 D
Common Stock 11/13/2012 S( 1 ) 792 D $ 148.05 ( 5 ) 87,133 D
Common Stock 11/14/2012 S( 1 ) 1,556 D $ 147.65 ( 6 ) 85,577 D
Common Stock 11/14/2012 S( 1 ) 900 D $ 148.65 ( 7 ) 84,677 D
Common Stock 11/14/2012 S( 1 ) 700 D $ 149.18 ( 8 ) 83,977 D
Common Stock 5,560 I By 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $ 8.5 11/13/2012 M( 1 ) 3,431 ( 9 ) 12/20/2012 Common Stock 3,431 ( 10 ) 0 D
Non-Qualified Stock Option (right to buy) $ 65.76 11/13/2012 M( 1 ) 4,745 09/06/2011 12/20/2012 Common Stock 4,745 ( 10 ) 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
GOLDBERG MURRAY A
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY10591
SVP Finance and Admin CFO Trea
Signatures
By: /s/**Douglas McCorkle For: /s/**Murray A. Goldberg 11/15/2012
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
( 2 )Represents volume-weighted average price of sales of 300 shares of Company stock on November 13, 2012 at prices ranging from $145.47 to $145.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.
( 3 )Represents volume-weighted average price of sales of 1,400 shares of Company stock on November 13, 2012 at prices ranging from $146.00 to $146.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.
( 4 )Represents volume-weighted average price of sales of 3,845 shares of Company stock on November 13, 2012 at prices ranging from $147.00 to $147.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.
( 5 )Represents volume-weighted average price of sales of 792 shares of Company stock on November 13, 2012 at prices ranging from $148.00 to $148.12. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.
( 6 )Represents volume-weighted average price of sales of 1,556 shares of Company stock on November 14, 2012 at prices ranging from $147.27 to $147.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.
( 7 )Represents volume-weighted average price of sales of 900 shares of Company stock on November 14, 2012 at prices ranging from $148.19 to $148.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.
( 8 )Represents volume-weighted average price of sales of 700 shares of Company stock on November 14, 2012 at prices ranging from $149.04 to $149.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.
( 9 )The option became exercisable with respect to all shares underlying the option upon the satisfaction by the company of certain performance criteria on February 10, 2012.
( 10 )Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.